Irreversible Electroporation (IRE): Standardization of Terminology and Reporting Criteria for Analysis and Comparison
暂无分享,去创建一个
Markus Porsch | Martin Schostak | Frank Fischbach | Jens Ricke | Maciej Pech | Katharina Fischbach | Daniel Baumunk | J. Köllermann | F. Fischbach | M. Schostak | M. Pech | M. Porsch | J. Ricke | U. Liehr | D. Baumunk | Johann J Wendler | Julian Jürgens | Jens Köllermann | Uwe-Bernd Liehr | J. Wendler | K. Fischbach | J. Jürgens | J. J. Wendler | Julian H. W. Jürgens
[1] J. Cardella,et al. Society of Interventional Radiology clinical practice guidelines. , 2003, Journal of vascular and interventional radiology : JVIR.
[2] D. D. de Bruin,et al. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol , 2014, BMJ Open.
[3] Robert C. G. Martin,et al. Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliation , 2014, BMC Cancer.
[4] M. Lee,et al. Terminology and Reporting Criteria for Radiofrequency Ablation of Tumors in the Scientific Literature: Systematic Review of Compliance with Reporting Standards , 2014, Korean journal of radiology.
[5] C. Bassi,et al. Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study , 2015, Digestive Surgery.
[6] Robert C. G. Martin,et al. Intra - operative Anesthesia Management in Patients Undergoing Surgical Irreversible Electroporation of the Pancreas, Liver, Kidney, and Retroperitoneal Tumors , 2015, Anesthesiology and pain medicine.
[7] Ian A. Donaldson,et al. A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT) , 2014, Contemporary clinical trials.
[8] J. Köllermann,et al. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). , 2015, Contemporary clinical trials.
[9] T. Vogl,et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Journal of vascular and interventional radiology : JVIR.
[10] H. Shimada,et al. Micrometastatic colorectal cancer lesions in the liver , 1998, Surgery Today.
[11] R. Lencioni,et al. Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours , 2009, CardioVascular and Interventional Radiology.
[12] Hirofumi Fujii,et al. Radiologic measurements of tumor response to treatment: practical approaches and limitations. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.
[13] Suyashree Bhonsle,et al. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy , 2015, The Prostate.
[14] G. Narayanan,et al. Vessel Patency Post Irreversible Electroporation , 2014, CardioVascular and Interventional Radiology.
[15] T. Baère,et al. Irreversible Electroporation (IRE) Fails to Demonstrate Efficacy in a Prospective Multicenter Phase II Trial on Lung Malignancies: The ALICE Trial , 2015, CardioVascular and Interventional Radiology.
[16] M. Makuuchi,et al. Scenario 1 : Complication After a Surgical Procedure Not Caused by a Surgeon , 2022 .